Comparison 5. Ranibizumab versus bevacizumab.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Change in visual acuity at 1 year | 2 | 80 | Mean Difference (IV, Fixed, 95% CI) | ‐0.02 [‐0.11, 0.06] |
2 Gain 3+ lines of visual acuity at 1 year | 2 | 80 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.79 [0.50, 1.27] |
3 Choroidal neovascularisation angiographic closure at 1 year | 2 | 80 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.08 [0.95, 1.22] |